Current Advantage and Prescription Drug Plan customers are not affected

The Centers for Medicare and Medicaid Services brought sanctions against Cigna-Healthspring January 21.

Cigna-Healthspring cannot enroll new beneficiaries into its Medicare Advantage and Prescription Drug plans. They are also prevented from marketing efforts. Cigna supplement plans are not involved in the suspension. The sanctions will be removed when the problems are solved, which will be decided by Medicare.

Why?
The sanctions are a result of Cigna’s poor responses to customer complaints and appeals, and problems with the Part D formulary and benefits. These problems led to difficulty obtaining and denials of treatment and medications, and increased costs.

What about those in the plans?
Current members of Cigna-Healthspring Advantage and Prescription Drug Plans are not affected. Coverage will remain and the hope is that Cigna, under the oversight of Medicare, will solve the problems that led to the sanctions.

If you’ve experienced problems with your Cigna-Healthspring plan, file a complaint with them or with Medicare. Fill out the Medicare Complaint Form here, or learn more about complaints on Medicare.gov.

How long will this last?
The sanctions will be withdrawn when the problems are fixed. That could last as long as six months, a year, or possibly into 2017. Cigna must submit a plan to correct the issues to Medicare by January 29.

✶ In the very near future, Tom will have Word Seek, Crossword and Sudoko books for clients. If you would like one, please respond to this email or call us at 804-788-1965 ✶

Here’s what to know before the snow comes this weekend

Chances are, you’ve heard the forecast for snow starting Friday. In case power is lost or you’re unable to travel, or if you’re just planning a trip to the grocery store before it hits, here are some tips to keep you safe and warm until the snow melts.

Foods.

  • Water. You can buy bottled water, or fill bottles at home with water ahead of time. Generally, there should be enough for 1 gallon per person per day.
  • Non-perishables. Some basic options are granola bars, trail mix, cereal, crackers, peanut butter and bread. Fruits and vegetables are good to have on hand, too.
  • Some dairy products. Hard cheeses (Cheddar, Colby, etc.) are safe to keep un-refrigerated if they are wrapped and sealed. Yogurt can also be left out of the fridge for up to 8 hours. Since it’s so cold, even if power went out, these items would still be safe to eat.
  • Pet Food. Don’t forget Fido! Be sure to have plenty of food on hand for your pet.
  • Store hours:
    • Kroger and Martin’s are open 6am-12am.
    • Food Lion is open 7am-11pm (some close at 10pm).
    • WalMart hours vary; some are open 24 hours and others are open 6am-12pm.

Items

  • Medications. Enough to last you a few days if you won’t be able to get a refill.
  • Blankets, hats, mittens and scarves. These will keep you warm if you must go outside, and if your power goes out inside. A good pair of winter shoes or snow boots will come in handy, too.
  • Light. Keep flashlights, lanterns and candles within reach. Be sure to have a stock of extra batteries and matches.
  • Heat source. A portable heater, firewood for your fireplace or a wood-burning stove are heat alternatives if you lose power.
  • Non-clumping kitty litter. Sprinkling a bit of this in your path will prevent slipping when walking outside. You can use rock salt or sand for the same purpose.

Safety numbers

  • Emergency contact numbers. Neighbors, or family and friends who live close by.
  • Dominion: 1-866-DOM-HELP (1-866-366-4357)
  • VEPCO: 804-224-8817
  • Keep a cell phone charged!

So, you might be stuck inside all weekend. What is there to do? You’re already online, so here are some options:

✶ In the very near future, Tom will have Word Seek, Crossword and Sudoko books for clients. If you would like one, please respond to this email or call us at 804-788-1965 ✶

New tool shows the drugs with the highest costs for Parts B and D

Medicare has created an online dashboard to show which drugs have the highest spending among Part B and Part D plans.

In the interest of transparency, CMS aims to make public the trends surrounding drug spending by Medicare and Medicare beneficiaries. They hope to start a discussion about the costs of drugs and how they could be changed.

If a drug ranks high for spending, cost increase or cost to users, it was considered for the dashboard. Overall, the dashboard represents a large portion of total spending by Medicare. The Part D drugs show 33% of overall spending. The Part B drugs show 71%.

Below are three Part D charts and information on the drugs included. See Part B charts on the online dashboard (link below).

Trends in Medicare Part D Total Spendingfor the Top 5 Drugs in 2014.

mm1

  • Abilify: treats schizophrenia, bipolar disorder, and others.
    • Generic: Aripiprazole.
  • Advair Diskus: treats asthma and COPD.
    • Generic: None
  • Crestor: treats high cholesterol and high levels of triglycerides.
    • Generic: There is no generic version of Crestor, or Rosuvastatin Calcium. There are generic statin drugs, which are generic forms of other brand drugs, but no generic version of Rosuvastatin.
  • Nexium: treats GERD.
    • Generic: Esomeprazole Magnesium
  • Sovaldi: treats hepatitis C.
    • Generic: None

 

 

 

 

Annual Spending per User by Total Spending for Medicare Part D Drugs: 2014. 

mm2

  • Tracleer: treats pulmonary artery hypertension.
    • Generic: None
  • Gleevec: treats leukemia and other types of cancer.
    • Generic: Sales of the generic imatinib mesylate will begin in February. The drug was approved in December.
  • Olysio: treats hepatitis C.
    • Generic: None
  • Sovaldi: treats hepatitis C.
    • Generic: None
  • Copaxone: treats multiple sclerosis.
    • Generic: Glatopa
  • Humira: treats arthritis, Crohn’s disease, and others.
    • Generic: Adalimumab

 

 

 

 

Medicare Part D Drugs with Large Increases in Cost per Unit, 2013 to 2014.

mm3

  • Vimovo: PPI/ NSAID; treats arthritis, pain and other conditions.
    • Generic: Esomeprazole/ Naproxen
  • Captopril: ACE inhibitor; treats high blood pressure and kidney problems.
    • Generic: Already generic
  • Digoxin/ Digox: treats heart failure and heart rhythm disorders.
    • Generic: Digoxin; (Digox is a brand drug)
  • Prednisolone Acetate: treats eye conditions.
    • Generic: Already generic
  • Clobetasol Propionate: treats skin conditions.
    • Generic: Already generic

To see the online dashboard, click here.

To learn more about the online dashboard, see this article from the Washington Post.

 

 

Change will save millions by preventing fraudulent claims

Prior authorization will now be necessary before Medicare will cover medical equipment such as wheelchairs and prosthetics. Prior authorization has always been required, but now it will be earlier in the process.

Why?
Fraudulent billing for these types of equipment costs Medicare millions. They expect to save big: $10 million in the first year, $200 million within five years and $580 million within ten years. In 2014, “the error rate among durable medical equipment billing was 53.1%, which accounted for $5 billion in improper payments that year.” Not all of those were intentionally fraudulent, but this new rule intends to correct many of those cases.

What is prior authorization?
Before an insurance company will cover something- a prescription or procedure- they will need to talk to your doctor and determine if they will cover it. If not, they could cover a substitute, change the dosage, or provide an alternative.
In this case, before Medicare will cover a piece of medical equipment, they will need to talk to your doctor earlier in the process than they previously had.

What equipment is affected?
The Master List of equipment that requires prior authorization includes items with “a high rate of fraud or unnecessary utilization.” They are also items that have an average purchase cost over $1,000 or an average rental cost over $100.
After 10 years, items are removed from the list. They will also be removed if the prices fall before then. In addition to wheelchairs and prosthetics, equipment like oxygen supplies, orthotics, and braces are listed.

Are there any concerns with this plan?
Some groups are concerned that the new rule will increase wait times for equipment that patients need ASAP.

To read the Centers for Medicare and Medicaid Services’ press release on the change, click here.

For more information on the prior authorization process, see this article from Healthcare Finance.

Approving new applications could significantly lower the cost of drugs

The question is how to reduce drug prices. The solution could be found in the Food and Drug Administration.

In recent months, politicians and organizations have written to the FDA, calling for the Office of Generic Drugs to reduce their overloaded system holding thousands of applications for new medications. Each of these 3,000 applications, called ANDAs (Abbreviated New Drug Applications), is a submission for a new generic drug.

Why is this important?

Generic drugs can cost up to 80% less than brand drugs. Of all prescriptions filled in the U.S., 86% are for generic drugs. Introducing new generics into the marketplace could increase competition and bring down prices across the board.

Is this a new problem?

The FDA will always have a backlog of new applications, says RAPS.org. The Office of Generic Drugs has been receiving more applications than it can feasibly look over.

However, other groups have noticed the problem getting worse. The Healthcare Supply Chain Association (HSCA) wrote in a letter to the FDA that approval time for generic drugs increased almost a full year from 2012 to 2014. They also said the Administration has approved fewer generic drugs each year for the last three years.

More generic drug applications are being submitted likely because so many patents are expiring. Drug patents originally issued in the 1980’s and 1990’s are nearing their end, opening up the opportunity for generic versions to exist.

Has anything been done?

In the last few months, the issue has gained traction. Senator David Vitter (R-LA) wrote a letter to the Acting Commissioner of the FDA urging the Administration to reduce the backlog of generic drug applications.

Democratic Presidential candidate Hillary Clinton also wrote to the FDA, calling for expediting pending applications and clearing the backlog.

For more on the FDA’s generic drug applications, see this article from the Wall Street Journal.

Click here to learn more about the FDA’s drug approval process.

Express Scripts will offer a $1 alternative to the $750 dollar pill. 

In September, we wrote about Daraprim, which originally cost $13.50 per pill, and skyrocketed to $750 overnight. Last week, Express Scripts announced that they would offer a cheaper alternative. Express Scripts is the largest pharmacy benefits manager in the country.

What is the new drug?

The company partnered with Imprimis Pharmaceuticals to create a slightly different pill- not a generic version, which would require approval by the FDA. Theirs has pyrimethamine, the main drug in Daraprim, and leucovorin, which is commonly prescribed with Daraprim to control its’ side effects. It will cost $99 for a bottle of 100 pills- less than $1 each.

What is the old drug?

Daraprim is a decades-old drug that is used to treat toxoplasmosis, a rare infection that typically affects those with decreased immune systems. Since the disease is so uncommon, there was never a push for a generic version of the medication that treats it. The drug Express Scripts offers is cheaper than Daraprim’s price, even before Turing Pharmaceuticals raised it from $13.50 to $750. After public outrage at the price hike, the CEO of Turing Pharmaceuticals, Martin Shrkeli, said that hospitals would be offered discounts of up to 50%.

Why?

Express Scripts was motivated to help patients and the doctors treating them. After hearing from many infectious disease doctors, the Chief Medical Officer at Express Scripts, Dr. Steve Miller, began looking for a solution.

Now, “the use of this compounded medication could theoretically reduce a hospital’s cost of treating a patient with Daraprim from as much as $40,000 to less than $60,” Ron Shinkman wrote on Fierce Health Finance.

See more about Express Scripts, Imprimis and their drug on CNBC.com.

Will Express Scripts’ decision impact healthcare and pharmaceutical prices? Read more here.

Most plans will see a small increase 

The new 2016 Prescription Drug Plans will cost more than they did this year.

There are a few signs of rising costs, from U.S. News and World Report:

Switching to a different plan will help beneficiaries save money, but The Kaiser Family Foundation says that overall, this could be the biggest increase since 2009.

In Virginia, the average monthly premium for 2016 Prescription Drug Plans will increase 19%, according to the Kaiser Family Foundation.

 

Aims to improve quality and cost of care

Medicare will implement new system for hospitals performing hip and knee replacements, which are the most common surgeries among Medicare beneficiaries. If hospitals don’t meet the standards, they will have to pay back a part of the cost to Medicare. If they do perform well, they will get a monetary reward.

What is the new program?
The Comprehensive Care for Joint Replacement model (or the CCJR model) aims at better quality care. It will begin April 1, 2016.
67 geographic areas are included in the program. The Staunton-Waynesboro area is the only one in Virginia.

How does it work?
Hospitals will be evaluated for an “episode of care,” which lasts 90 days after the surgery. The cost of the episode of care, including the procedure and any related care, is in question for the hospital.

If the hospital’s care doesn’t meet the cost and quality standards, they will owe Medicare for a portion of the cost for the episode of care. If they succeed, Medicare will give the hospital a financial reward.

The program is meant to create incentives not only for hospitals, but skilled nursing facilities, nursing homes, and other health providers to providing comprehensive, coordinated care.

Why start this program?
The Centers for Medicare and Medicaid Services say on their website that these surgeries are the most common among beneficiaries, but the care varies from hospital to hospital. They want to not only coordinate the quality of care and its costs, but improve care nationwide. The inconsistencies in the health of patients after these surgeries reflects the state of the entire health care system.

 

Prices vary for current and new beneficiaries

The White House announced the 2016 Medicare Part B premiums this week. They are significantly less than expected- you can see the original predictions in a previous newsletter. Here’s what you need to know:

Premiums: The Part B premium will increase for new beneficiaries and some current beneficiaries.

  • Current Beneficiaries: Most current beneficiaries will pay $104.90 per month, the same as this year.
  • New Beneficiaries: New beneficiaries will pay an increased premium of $121.80 per month.
  • High-income Beneficiaries: Beneficiaries making certain amounts will have a higher premium Those making over $85,000 a year will pay $170.50. The prices increase incrementally, up to a premium of $389.80 for those making over $214,000 per year.
Deductible: The Part B deductible will increase for all beneficiaries. It has been $147 since 2013.
  • Current Beneficiaries: Current beneficiaries will pay $166.
  • New Beneficiaries: New beneficiaries will pay $166.

Do you have a favorite saying that was passed down from your grandparents, parents or other family members?

Tom wants to hear it!

Share it with us by responding to this email.

Tom would love for you refer our newsletter to a friend or family member. We are trying very hard to grow our newsletter and want to share it with more people. If you like it and wish to forward it to someone else, we would greatly appreciate it!

See this article by U.S. News & World Report for more details on the 2016 Part B premium prices.

Read The White House’s post about the 2016 Medicare Part B Premiums on their website.

 

In addition to other Social Security changes in the budget, Congress targeted methods that permitted beneficiaries to increase their own Social Security benefits while collecting their spouse’s checks. Waiting to collect benefits yields a larger payout- after full retirement age (currently 66), benefits increase 8 percent per year until age 70.

Losing this option could be costly for seniors- some couples can make up to $60,000 filing this way. But for the government, the cost is even greater: if everyone took advantage of these loopholes, the cost to the Social Security Administration would be over $9 billion.

These are the two main strategies outlawed by the budget rules:

File-and-suspend: This loophole allowed a person to file for benefits and suspend those benefits right away. Their benefits would grow by a small percentage while they collected their spouse’s benefits.

Restricted application: Filing a restricted application at age 66 (or full retirement age) would let a person collect their spouse’s benefits while their own benefits grow untouched.

The law will go into effect May 1, 2016. After this date, these strategies will not be available. If you will be 66 before May 1, 2016, you have time to take advantage of these strategies before they are longer an option. The law will mostly affect new retirees, who will not have the strategy available to them.

Budget will end options that allowed married couples to maximize benefits

To read more about File-and-Suspend, see this Forbes article.

See this piece from the Washington Post for more background on the stratgies and other options for claiming benefits.

Sign up for our newsletter!
The latest in Medicare news, weekly.
My Medicare Planner
myMedicarePlanner.com